Table 2 Inclusion and exclusion criteria per group
From: The role of URO17® in diagnosis and follow up of bladder cancer patients
Group I | Group II | |
|---|---|---|
Inclusion criteria | - Patients aged ≥ 18 years of age - Patients with visible or microscopic haematuria | - Age > 18 - Non-muscle invasive bladder cancer and upper tract urothelial cancer patients on regular follow up |
Exclusion criteria | - Patients aged < 18 years of age - Patients with catheter in situ - Patients who are currently undergoing radiation therapy - Patients currently on investigational drug trials. - Patients refused to participate or lack the capacity to sign the consent | - Age < 18 - Muscle-invasive bladder cancer patients - Patients currently on investigational drug trials - Patients refused to participate or lack the capacity to sign the consent |